IperionX Strengthens U.S. Critical Minerals Strategy with Camden Acquisition
IperionX Limited (ASX: IPX) has completed the acquisition of the Camden critical minerals project in Tennessee, significantly strengthening its position alongside the adjacent Titan Project. The acquisition provides access to ultra-high-grade surface stockpiles containing titanium, zircon, and heavy rare earth minerals, with recorded total heavy mineral grades substantially exceeding the average grade of the Titan resource. The transaction also includes established infrastructure such as power, water, natural gas, and rail connectivity, which could reduce future development costs and accelerate project timelines. Additionally, historical mining activities have exposed high-grade mineralised zones, enabling easier access for future resource development. The company plans to undertake drilling, metallurgical testing, and integrated economic studies during 2026 to evaluate the combined Camden-Titan development pathway. By integrating upstream mineral resources with its downstream titanium processing capabilities, IperionX aims to support a secure domestic supply of critical minerals for U.S. defence, aerospace, advanced manufacturing, and technology industries.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
IperionX Strengthens U.S. Critical Minerals Strategy with Camden Acquisition
IperionX Limited (ASX: IPX) has completed the acquisition of the Camden critical minerals project in Tennessee, significantly strengthening its position alongside the adjacent Titan Project. The acquisition provides access to ultra-high-grade surface stockpiles containing titanium, zircon, and heavy rare earth minerals, with recorded total heavy mineral grades substantially exceeding the average grade of the Titan resource. The transaction also includes established infrastructure such as power, water, natural gas, and rail connectivity, which could reduce future development costs and accelerate project timelines. Additionally, historical mining activities have exposed high-grade mineralised zones, enabling easier access for future resource development. The company plans to undertake drilling, metallurgical testing, and integrated economic studies during 2026 to evaluate the combined Camden-Titan development pathway. By integrating upstream mineral resources with its downstream titanium processing capabilities, IperionX aims to support a secure domestic supply of critical minerals for U.S. defence, aerospace, advanced manufacturing, and technology industries.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au